drugset / Trial / NCT05079425
A First-in-Human Study to Assess Single and Multiple Doses of NXC736 in Healthy Participants
RandomizedSequentialQuadruple-blindOther
Summary
This is a randomized, double-blind, placebo- controlled, single and multiple dosing, dose-escalation clinical phase 1 trial to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of NXC736 after oral administration in healthy male volunteers.
Timeline
- Start
- 2021-09-01
- Primary completion
- 2022-11-01
- Completion
- 2022-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NXC736 | Unknown | — | Oral |
Indications
No indication recorded.